Tourette syndrome
Tic disorder. Limited evidence for THC capsules.
What the evidence says
NASEM 2017: limited evidence for improving symptoms of Tourette syndrome (THC capsules).
NASEM found limited evidence that THC capsules improve symptoms of Tourette syndrome. The trials were small.
This is an area where specialist neurology input matters, particularly because Tourette syndrome frequently begins in childhood and cannabis carries specific risks for the developing brain.
What to ask for
This is a starting point, not a prescription. Take it to a licensed dispensary and ask to see the batch certificate of analysis.
- Suggested ratio
- THC-forward
- Starting THC dose
- 2.5 mg
- Commonly chosen profile
- Balanced hybrid
- Time of day
- either
Cannabinoids
- THC
The main intoxicating compound in cannabis. It drives most of what people mean by "high," and it is also the cannabinoid behind most documented therapeutic effects.
Terpenes to look for
Commonly present in products people choose for this. Terpene effect claims are preclinical — this is a way to find a product again, not a promise about how it will feel.
Formats
Get a personalised starting point
Answer four questions and we will adjust the dose for your experience level and find licensed dispensaries near you.
Get guidanceTalk to a doctor if
- • The person affected is under 25 — discuss developmental risk with a neurologist first
- • Tics are causing injury
Related conditions
- Multiple sclerosis spasticityMuscle stiffness and spasm in multiple sclerosis. Substantial evidence for patient-reported improvement; weaker for clinician-measured.
- DementiaNASEM found limited evidence that cannabinoids are INEFFECTIVE for dementia symptoms.
- Epilepsy and seizure disordersPrescription CBD has strong RCT evidence in three specific syndromes. Dispensary products do not.
- ADHDAttention-deficit/hyperactivity disorder. No supporting evidence, and acute cannabis use impairs attention.